Daniel Leon Abravanel, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oximes | 1 | 2018 | 303 | 0.540 |
Why?
|
| Pyrimidinones | 1 | 2018 | 385 | 0.500 |
Why?
|
| Pyridones | 1 | 2018 | 809 | 0.410 |
Why?
|
| Receptors, Notch | 2 | 2015 | 743 | 0.410 |
Why?
|
| Imidazoles | 1 | 2018 | 1173 | 0.390 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2024 | 2054 | 0.330 |
Why?
|
| Receptor, erbB-2 | 2 | 2024 | 2553 | 0.260 |
Why?
|
| Androstadienes | 1 | 2024 | 348 | 0.200 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 2452 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 8529 | 0.180 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2024 | 736 | 0.170 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 20981 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 2011 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 9278 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9416 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2015 | 23415 | 0.110 |
Why?
|
| Molecular Imaging | 1 | 2021 | 819 | 0.110 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 4908 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13382 | 0.110 |
Why?
|
| Piperazines | 1 | 2024 | 2522 | 0.110 |
Why?
|
| Pyridines | 1 | 2024 | 2872 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3869 | 0.100 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2010 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 1381 | 0.090 |
Why?
|
| Mice, Nude | 1 | 2015 | 3604 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2015 | 1741 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 6123 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3776 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9518 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 619 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5300 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 559 | 0.040 |
Why?
|
| Dendritic Spines | 1 | 2021 | 242 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1726 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 220835 | 0.030 |
Why?
|
| Female | 5 | 2024 | 392458 | 0.030 |
Why?
|
| Mice | 3 | 2021 | 81324 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 30006 | 0.030 |
Why?
|
| Visual Cortex | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Biopsy | 1 | 2024 | 6781 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5366 | 0.020 |
Why?
|
| Macrophages | 1 | 2024 | 5754 | 0.020 |
Why?
|
| Humans | 6 | 2024 | 761098 | 0.020 |
Why?
|
| Cyclic S-Oxides | 1 | 2009 | 25 | 0.020 |
Why?
|
| Animals | 3 | 2021 | 168083 | 0.020 |
Why?
|
| Thiadiazoles | 1 | 2009 | 63 | 0.020 |
Why?
|
| Genomics | 1 | 2024 | 5828 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 10203 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 11732 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 169266 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15542 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16947 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13506 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 221083 | 0.010 |
Why?
|